News | Medical Marketing & Media | MM&M

News

FDA approves Abilify

Bristol-Myers Squibb and Otsuka Pharmaceutical Company won FDA approval for Abilify…

FCB lands two DTC accounts

FCB was awarded the DTC advertising for Hoffman-LaRoche’s two drugs, Pegasys and Copegus, that treat hepatitis C. Annual media spending for upcoming campaigns could exceed $30 million, sources said.

Merck pulls plug on Vioxx; rivals step up promo efforts

In the wake of Merck’s decision to withdraw Vioxx because of unfavorable clinical trials data, Pfizer and Boehringer Ingelheim/Abbot Laboratories have stepped up efforts to
promote their respective rival COX-2 inhibitors, Celebrex and Mobic.

Revised CME guidelines could drive best speakers from stage

The Accreditation Council for Continuing Medical Education (ACCME) ratified a revision of its Standards for Commercial Support that some fear could effectively prohibit physicians accepting honoraria from drug companies from conducting accredited CME.

Lacquaniti eyes expansion

The selection process was described as extensive and exhaustive, but now that Mary Lacquaniti is settling into her new role as executive director of the Healthcare Marketing and Communications Council (HMC), she is focused on the future.

Pfizer Pfriends program underway

Pfizer announced today that America’s uninsured can now obtain Pfizer prescription medicines at significant savings through more than 52,000 community pharmacies nationwide or via Pfizer’s mail order service. The savings are available through Pfizer’s new program, Pfizer Pfriends.

Giant wins ArgiNox account

ArgiNox Pharmaceuticals, of Menlo Park, Ca named Giant Creative Strategy as the agency of record for their lead compound, tilarginine acetate. Tilarginine acetate is currently being studied in clinical trials for the treatment of cardiogenic shock. Giant will work with ArgiNox to develop an integrated scientific market preparation campaign, as well as naming and all…